H.C. Wainwright’s $140 target on MIRM

MIRM Mirum Pharmaceuticals Inc

$88 → $140 (+59%) by Sep 2027

Buy · reiterates · said Sep 28, 2026 · 12-month default horizon

Open: judged on the close on Sep 28, 2027

The article this target came from

Citizens raises Mirum Pharmaceuticals stock price target on HDV data

Investing.com · Sep 28, 2026

reiterated a Buy rating with a $140 price target, highlighting the competitive efficacy and clean safety profile

H.C. Wainwright’s track record → Mirum Pharmaceuticals Inc →

A fact about what H.C. Wainwright published, as reported by Investing.com, not a recommendation from Dalsna Finance; H.C. Wainwright is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.